Evaluation of the neuroprotective activity of a new allylmorpholine derivative in a rat model of traumatic brain injury
Introduction. The search for and development of new drugs capable of reducing the severity of neurological deficit in traumatic brain injury are a critical task for investigational pharmacology. Chromone-containing allylmorpholines are a new group of neuroprotective drug candidates that have been sh...
Main Authors: | V. A. Prikhodko, A. V. Kan, Yu. I. Sysoev, I. A. Titovich, N. A. Anisimova, S. v Okovityi |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-12-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/1118 |
Similar Items
-
Novel Chromone-Containing Allylmorpholines Induce Anxiolytic-like and Sedative Effects in Adult Zebrafish
by: Veronika A. Prikhodko, et al.
Published: (2022-11-01) -
Effects of Alpha-2 Adrenergic Agonist Mafedine on Brain Electrical Activity in Rats after Traumatic Brain Injury
by: Yuriy I. Sysoev, et al.
Published: (2021-07-01) -
THE SEARCH FOR NEUROPROTECTIVE COMPOUNDS AMONG NEW ETHYLTHIADIAZOLE DERIVATIVES
by: R. F. Cherevatenko, et al.
Published: (2021-01-01) -
Neuroprotective Properties of Chitosan and Its Derivatives
by: Se-Kwon Kim, et al.
Published: (2010-07-01) -
Evaluation of the efficacy and safety of cytoflavin as a neuroprotector based on a systematic review
by: E. K. Krasova, et al.
Published: (2023-09-01)